Q4 EPS Forecast for Tenet Healthcare Decreased by Analyst

Tenet Healthcare Co. (NYSE:THC) – Investment analysts at Zacks Research reduced their Q4 2024 earnings per share estimates for Tenet Healthcare in a report released on Wednesday, December 18th. Zacks Research analyst R. Department now expects that the company will earn $2.87 per share for the quarter, down from their previous estimate of $2.88. The consensus estimate for Tenet Healthcare’s current full-year earnings is $11.38 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q2 2025 earnings at $2.66 EPS, Q4 2025 earnings at $3.20 EPS and Q1 2026 earnings at $3.45 EPS.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share for the quarter, beating the consensus estimate of $2.33 by $0.60. Tenet Healthcare had a net margin of 14.91% and a return on equity of 24.05%. The firm had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.05 billion. During the same period in the previous year, the firm posted $1.44 earnings per share. The business’s revenue was up 1.1% compared to the same quarter last year.

A number of other equities research analysts have also commented on THC. Cantor Fitzgerald increased their price target on Tenet Healthcare from $168.00 to $177.00 and gave the company an “overweight” rating in a research report on Wednesday, October 30th. UBS Group upped their price objective on shares of Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Barclays boosted their target price on Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a research note on Friday, November 8th. The Goldman Sachs Group lowered Tenet Healthcare from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $196.00 to $140.00 in a report on Monday, December 16th. Finally, Raymond James downgraded Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price objective for the company. in a research note on Friday, November 22nd. Three research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $166.88.

Tenet Healthcare Stock Up 3.0 %

Tenet Healthcare stock opened at $129.46 on Monday. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. The firm’s fifty day moving average price is $149.74 and its two-hundred day moving average price is $149.14. The firm has a market capitalization of $12.31 billion, a price-to-earnings ratio of 4.15, a price-to-earnings-growth ratio of 0.61 and a beta of 2.06. Tenet Healthcare has a 1-year low of $73.21 and a 1-year high of $171.20.

Insiders Place Their Bets

In related news, EVP Lisa Y. Foo sold 4,000 shares of the business’s stock in a transaction that occurred on Thursday, October 31st. The stock was sold at an average price of $155.94, for a total transaction of $623,760.00. Following the completion of the transaction, the executive vice president now directly owns 15,566 shares in the company, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.93% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds have recently made changes to their positions in THC. Coldstream Capital Management Inc. boosted its stake in Tenet Healthcare by 2.2% during the third quarter. Coldstream Capital Management Inc. now owns 3,406 shares of the company’s stock valued at $566,000 after buying an additional 74 shares during the last quarter. Optas LLC increased its position in Tenet Healthcare by 3.4% in the third quarter. Optas LLC now owns 2,821 shares of the company’s stock worth $469,000 after purchasing an additional 93 shares during the last quarter. Signaturefd LLC lifted its position in Tenet Healthcare by 17.6% during the third quarter. Signaturefd LLC now owns 628 shares of the company’s stock valued at $104,000 after purchasing an additional 94 shares during the last quarter. CIBC Asset Management Inc increased its holdings in shares of Tenet Healthcare by 3.4% in the 3rd quarter. CIBC Asset Management Inc now owns 2,887 shares of the company’s stock worth $480,000 after buying an additional 94 shares during the last quarter. Finally, EverSource Wealth Advisors LLC lifted its holdings in shares of Tenet Healthcare by 20.7% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 560 shares of the company’s stock valued at $74,000 after acquiring an additional 96 shares during the last quarter. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.